RIDAQ 12.5 mg Tablet Ref.[107965] Active ingredients: Hydrochlorothiazide

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2023  Publisher: PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

5.1. Pharmacodynamic properties

Category and class: A 18.1 Diuretics
Pharmacotherapeutic group: Medicines acting on reno- urinary and genital system
ATC code: C03AA03

Mechanism of action

Hydrochlorothiazide is a diuretic which reduces the reabsorption of electrolytes from the renal tubules, thereby increasing the excretion of sodium, potassium and chloride ions, and consequently of water. It also slightly increases bicarbonate excretion without appreciable alteration of the acid-base balance or the pH of the urine. It has a lowering effect on the blood pressure and enhances the action of other hypotensive medicines such as guanethidine, methyldopa and rauwolfia alkaloids.

5.2. Pharmacokinetic properties

Absorption

Hydrochlorothiazide is absorbed from the gastrointestinal tract.

Distribution

Then distributed throughout the extracellular space and diffuses across the placenta.

Biotransformation

Diuresis occurs in about two hours, reaches a maximum in about four hours, and lasts for about twelve hours. Tolerance does not develop, and therapeutic efficacy is maintained when it is administered over long periods, but patients may not respond if their glomerular filtration-rate is markedly reduced.

Elimination

The route of elimination is via the kidneys.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.